Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters: Torré Anderson, II, Fourth Year Doctor of Pharmacy Candidate, Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health Ashley Ball, PharmD Candidate, LECOM-School of Pharmacy Macrina Ghali, PharmD Candidate 2021, Florida A&M University, College of Pharmacy and Pharmaceutical Sciences Kornelia Ilias, Creighton University | School of Pharmacy and Health Professions Doctor of Pharmacy Candidate Class of 2022 Alan Martinez, PharmD Candidate, University of South Florida Taneja College of Pharmacy | 
Many patients that wear a continuous glucose sensor also use pump therapy. This means at any time they have 2 injection sites in use on their body, and those sites are more often than not in the abdominal area. If the patient is a new user it is not a problem, but more seasoned users will seemingly run out of places to insert the devices. If you look at the patient on a Dexcom CGM and a T-Slim pump, they are inserting an average of 13 times a month. Although we tell patients that they only have to move a few centimeters away from a previously used site, that does not often happen. If the patient is using either a Freestyle Libre or an Omnipod they have the opportunity to use their upper arms as well.